Latest: Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient...
Latest: Cancer treatment monitoring: The value of minimal residual disease testing
Latest: Big Pharma: Tackling the industry’s greatest contamination risk
Latest: Shimadzu introduces iMScope™ QT Imaging Mass Microscope for high-level mass spectrometry...
Latest: UV7+LabX: Easy and efficient compliance
Latest: How a proactive and collaborative stakeholder-focused approach to risk mitigation...
Latest: MALDImini-1 - Minimum size, maximum performance
Virtual Cancer and Immunology Research Summit 2022: Registration now open
Big Pharma: Tackling the industry’s greatest contamination risk
Cancer treatment monitoring: The value of minimal residual disease testing
Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with...
9 upcoming webinars to optimize your scientific processes
8 upcoming webinars to help you to achieve your research goals
Managing the risk of nitrosamines in medicinal drugs
Your essential guide to preparative LC
Discover pioneering laboratory equipment and analytical technologies
Water and wastewater analysis
Rapid characterization of oligonucleotides using microfluidic capillary electrophoresis
Breath biopsy: The complete guide
DNA/RNA Purification and Analysis
Cell Counting Technology
Cell Analysis Microscopy Equipment
Virtual Cancer and Immunology Summit
Cancer and Immunology...
19 Jul 22 - 19 Jul 22
2022 AACC Annual Scientific...
24 Jul 22 - 28 Jul 22
Food Contamination: Quality,...
08 Aug 22 - 12 Aug 22
Food Analysis Summit 2022:...
03 Oct 22 - 04 Oct 22
21 Nov 22 - 22 Nov 22
LGC is an established biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...